Evaluation of Efficacy of Full-mouth Disinfection in Generalized

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether full-mouth disinfection is effective in the initial periodontal treatment of generalized aggressive periodontitis on clinical parameters, gingival crevicular fluid interleukin-1β (IL-1β) and interleukin-17 (IL-17) and periodontal pathogen levels compared with conventional initial periodontal treatment and full-mouth initial periodontal treatment.

The investigators' hypothesis is to test whether full-mouth disinfection in the initial periodontal treatment of generalized aggressive periodontitis enhance the clinical, biochemical and microbiological parameters in comparison to conventional initial periodontal treatment and full-mouth initial periodontal treatment.

Clinical Trial Description

The present study aimed to compare the efficacy of conventional initial periodontal treatment (C-IPT), full-mouth disinfection IPT (FMD-IPT) and full-mouth IPT (FM-IPT) and the levels of gingival crevicular fluid interleukin-1β (IL-1β) and interleukin-17 (IL-17), Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Fusobacterium nucleatum, Prevotella intermedia, Parvimonas micra and Campylobacter rectus in patients with generalized aggressive periodontitis (GAgP) over 6-months period. Forty-two GAgP patients were randomly assigned into 3 groups. IPT was performed in a quadrant-wise manner at 1-week intervals in C-IPT, in 2 sessions within 24 hours in FM-IPT, and in 2 sessions with application of chlorhexidine to the intra-oral niches within 24 hours in FMD-IPT. FMD-IPT group also used daily 0,2% chlorhexidine for 3 weeks. At baseline, 3 and 6 months clinical parameters consisting of plaque index, gingival index, probing depth, bleeding on probing and clinical attachment level were recorded, gingival crevicular fluid and microbiological samples were collected. Gingival crevicular fluid levels of IL-1β and IL-17 were analyzed using ELISA. The quantitative real-time polymerase chain reaction method was used for the quantitative detection of periodontal pathogens. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02466646
Study type	Interventional
Source	Marmara University
Contact
Status	Completed
Phase	Phase 4
Start date	December 2012
Completion date	September 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05043935` - The Effect of Leukocyte and Platelet-rich Fibrin With Antimicrobial Photodynamic Therapy in Aggressive Periodontitis	N/A
Terminated	`NCT01993368` - Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis	N/A
Completed	`NCT02282800` - Immunolocalization of 1,25,Dihydroxyvitamin D3 in Aggressive Periodontitis Patients	N/A
Recruiting	`NCT02833285` - B Cell Functions in Periodontitis
Completed	`NCT02127203` - Nitro-oxidative Stress in Periodontitis	N/A
Completed	`NCT02223702` - Alternative Antibiotic Regime in the Treatment of GAgP	Phase 4
Completed	`NCT03093246` - Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis	Phase 2/Phase 3
Completed	`NCT03093207` - Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis	Phase 2/Phase 3
Completed	`NCT05297084` - Non Surgical Periodontal Treatment Effect on Il-17 and Il-18 in Aggressive Periodontitis
Completed	`NCT05295576` - Effect of Non Surgical Periodontal Therapy on Inflammatory Markers in Chronic Periodontitis Patients
Completed	`NCT02969928` - Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis	Phase 2/Phase 3
Completed	`NCT02829983` - Clarithromycin as Adjuvant to Periodontal Debridement	N/A
Completed	`NCT02817568` - Frequency Of MCP-1 And CCR2 Gene Polymorphisms And Its Effect On Gene Expression In Patients With AgP	N/A
Completed	`NCT02927704` - Gingival Crevicular Fluid Levels Of Monocyte Chemoattractant Protein-1	N/A
Active, not recruiting	`NCT04051255` - Influence of Smoking on Clinical, Microbiological and Immunologic Parameters in Patients With Aggressive Periodontitis.	N/A
Completed	`NCT05001919` - Concentrated Growth Factors in Treatment of Intrabony Defects in Localized Aggressive Periodontitis	Phase 1/Phase 2
Completed	`NCT03727620` - Doxycycline in the Treatment of Aggressive Periodontitis	Phase 1/Phase 2
Completed	`NCT04223869` - IL-34 Levels in Various Types of Periodontitis	N/A
Completed	`NCT03034824` - Effects of Er,Cr:YSGG, Diode Lasers on GCF Cytokines Levels	N/A
Completed	`NCT02049008` - Treatment of Aggressive Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of Efficacy of Full-mouth Disinfection in Generalized Aggressive Periodontitis Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms